Brief: Ironwood Pharmaceuticals Reports First Quarter 2023 Results Maintains Full Year 2023 Financial Guidance
04/05/2023 12:12
Ironwood Pharmaceuticals Inc IRWD.O :
* IRONWOOD PHARMACEUTICALS REPORTS FIRST QUARTER 2023
RESULTS;
MAINTAINS FULL YEAR 2023 FINANCIAL GUIDANCE
* IRONWOOD PHARMACEUTICALS INC QTRLY GAAP NET INCOME PER
SHARE
-DILUTED $0.25
* IRONWOOD PHARMACEUTICALS INC QTRLY NON-GAAP NET INCOME PER
SHARE
- DILUTED $0.25
* IRONWOOD PHARMACEUTICALS INC -SEES 2023 TOTAL REVENUE $420
TO
$435 MILLION
Source text for Eikon: ID:nBw4hN9SHa
Further company coverage: IRWD.O
Recent news on Ironwood Pharmaceuticals
See all newsBrief: Ironwood Pharmaceuticals Appoints Tammi Gaskins As Chief Executive Officer
Ironwood Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ironwood Q2 revenue rises 33%
Brief: Ironwood Pharmaceuticals Repaid In Full $200 Million 1.5% Convertible Senior Notes Due 2026
Brief: FDA Approves Use Of Linzess In Pediatric Patients Aged 2 & Older With Functional Constipation